|

AMX0035 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Washington1

Indications

  • Combination Therapy1
  • Nutritional and Metabolic Diseases1
  • Diabetes Melletus, Type 11
  • Glucose Metabolism Disorders1
  • Type 1 Diabetes (T1D)1

Seattle, Washington1 trial

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

University of Washington Medicine Diabetes Institute (UWMDI)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.